Dose daily

Cipla Reports Q2 FY27 Financial Results: Consolidated Net Profit Plunges 35% to ₹878 Crore on North America Drag; India Business Grows 12%

Cipla Limited today announced its consolidated financial results for the second quarter ended September 30, 2026 (Q2 FY27), reporting a 35% year-on-year (YoY) decline in net profit after tax to...

​Piramal Pharma Reports Strong Q2 FY27 Performance with 28% Revenue Growth and 72% EBITDA Surge; Upgrades Full-Year FY27 Outlook

 Piramal Pharma Limited  announced its consolidated financial results for the second quarter (Q2) and half year (H1) ended September...

Orchid Pharma Partners with Laboratorio Libra to Expand Novel Antibiotic Exblifep®️ Across Latin America in $80 Million Agreement

Orchid Pharma Ltd., a Dhanuka Group company,  announced a licensing and supply agreement with Uruguay-based LaboratorioLibra S.A. to commercialize Exblifep® (cefepime/enmetazobactam) across...

Genentech Announces Pivotal Phase III Data for Divarasib Demonstrating Significant Survival Benefits in KRAS G12C-Mutated Lung Cancer

Genentech, a member of the Roche Group, today announced positive results from the pivotal Phase III Krascendo 1 clinical trial...

Corxel Pharmaceuticals to Go Public via $377 Million Business Combination to Accelerate Next-Generation Oral Obesity Pipeline

Corxel Pharmaceuticals announced today that it has entered into a definitive business combination agreement with AmanatAcquisition Corp. to take its...

Ambuja Neotia Healthcare Announces Investment to Set Up 120-Bed Woman and Child Hospital in Howrah

Ambuja Neotia Healthcare Venture Ltd (ANHVL) has unveiled plans to establish a 120-bed specialized woman and child care hospital in Howrah, West Bengal, committing an investment...

AbbVie Submits Regulatory Application to EMA for Subcutaneous Induction of SKYRIZI®️ in Crohn’s Disease

AbbVie announced the submission of a regulatory application to the European Medicines Agency (EMA) seeking approval for SKYRIZI® (risankizumab) for subcutaneous (SC) induction dosing...

FDA Approves Takeda’s First-in-Class Therapy MIMRYLO for Polycythemia Vera Following Robust Phase 3 Results

Takeda announced that the U.S. Food and Drug Administration (FDA) has approved MIMRYLO, a first-in-class therapy indicated for the treatment of polycythemia vera. Polycythemiavera is a rare, chronic...

Maharashtra FDA Withdraws Drug License Cancellation Order for Cipla C&F Unit Following Bombay High Court Rebuke

In a major regulatory development, the Maharashtra Food and Drug Administration (FDA) has withdrawn its order cancelingthe drug sale license of Cipla Pharma & Life Sciences Ltd’sCarrying and...

Orsini Partners with Priovant to Support Access to New Dermatomyositis Therapy LISRAYA

Orsini, a specialty pharmacy known for its work in rare disease care, has been named a specialty pharmacy partner for LISRAYA (brepocitinib), a newly...

‘Shwas Kavach’ Initiative Gains Government Recognition for AI-Enabled Last-Mile Medical Oxygen Network

Shwas Kavach, an initiative aimed at strengthening India's last-mile medical oxygen supply, has received recognition and support from the Office of the Principal Scientific Adviser (PSA) to...